Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR): Overall Survival Results of the SABR-5 Trial

Autor: Jiang, W.N., Baker, S., Liu, M., Bergman, A., Schellenberg, D., Mou, B., Alexander, A.S., Carolan, H., Atrchian, S., Chan, E.K., Mohamed, I.G., Berrang, T., Bang, A., Chng, N., Matthews, Q., Pai, H.H., Lefresne, S., Tyldesley, S., Olson, R.A.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:S147-S148
Databáze: ScienceDirect